Declining Lucentis Market Share Bodes Well for Regeneron's (REGN) Eylea -BMO
Tweet Send to a FriendGet Alerts REGN Hot Sheet
Price: $242.76 +4.32%
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade REGN Now!
Shares of Regeneron Pharma (Nasdaq: REGN) opened about 2 percent higher Thursday morning (although have since given up most gains) as traders are likely responding to comments from Roche on its wet AMD drug Lucentis.
On the company's first-quarter earnings conference call Thursday morning, a Roche exec said Lucentis market share declined moderately to 36 percent.
BMO Capital's Jim Birchenough highlighted the comment in a research note from earlier, saying the data suggests increased competition from Regeneron's Eylea. He believes "Lucentis sales in the context of a strong launch of Eylea with substantial patient switching suggests significant anti-VEGF category and brand expansion..."
Birchenough maintains an Outperform rating and $142 price target on shares of Regeneron Pharma.
The stock last traded at $121.89, up 0.4 percent from Wednesday's closing price.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
On the company's first-quarter earnings conference call Thursday morning, a Roche exec said Lucentis market share declined moderately to 36 percent.
BMO Capital's Jim Birchenough highlighted the comment in a research note from earlier, saying the data suggests increased competition from Regeneron's Eylea. He believes "Lucentis sales in the context of a strong launch of Eylea with substantial patient switching suggests significant anti-VEGF category and brand expansion..."
Birchenough maintains an Outperform rating and $142 price target on shares of Regeneron Pharma.
The stock last traded at $121.89, up 0.4 percent from Wednesday's closing price.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Terex (TEX) Suffers from Weakness in Europe; Read-Through For Manitowoc (MTW)
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BMO Capital, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
